Your browser doesn't support javascript.
loading
Show: 20 | 50 | 100
Resultados 1 - 20 de 168
Filtrar
1.
J Vet Pharmacol Ther ; 40(6): 629-640, 2017 Dec.
Artículo en Inglés | MEDLINE | ID: mdl-28470723

RESUMEN

The main objectives of this study were (i) to evaluate the serum pharmacokinetic behaviour and milk penetration of marbofloxacin (MFX; 5 mg/kg), after intravenous (IV) and intramuscular (IM) administration in lactating goats and simulate a multidose regimen on steady-state conditions, (ii) to determine the minimum inhibitory concentration (MIC) and mutant prevention concentration (MPC) of coagulase negative staphylococci (CNS) isolated from caprine mastitis in Córdoba, Argentina and (iii) to make a PK/PD analysis by Monte Carlo simulation from steady-state pharmacokinetic parameters of MFX by IV and IM routes to evaluate the efficacy and risk of the emergence of resistance. The study was carried out with six healthy, female, adult Anglo Nubian lactating goats. Marbofloxacin was administered at 5 mg/kg bw by IV and IM route. Serum and milk concentrations of MFX were determined with HPLC/uv. From 106 regional strains of CNS isolated from caprine mastitis in herds from Córdoba, Argentina, MICs and MPCs were determined. MIC90 and MPC90 were 0.4 and 6.4 µg/ml, respectively. MIC and MPC-based PK/PD analysis by Monte Carlo simulation indicates that IV and IM administration of MFX in lactating goats may not be adequate to recommend it as an empirical therapy against CNS, because the most exigent endpoints were not reached. Moreover, this dose regimen could increase the probability of selecting mutants and resulting in emergence of resistance. Based on the results of Monte Carlo simulation, the optimal dose of MFX to achieve an adequate antimicrobial efficacy should be 10 mg/kg, but it is important take into account that fluoroquinolones are substrates of efflux pumps, and this fact may determine that assumption of linear pharmacokinetics at high doses of MFX may be incorrect.


Asunto(s)
Antibacterianos/farmacocinética , Fluoroquinolonas/farmacocinética , Leche/química , Animales , Antibacterianos/administración & dosificación , Antibacterianos/análisis , Cromatografía Líquida de Alta Presión/veterinaria , Femenino , Fluoroquinolonas/administración & dosificación , Fluoroquinolonas/análisis , Fluoroquinolonas/uso terapéutico , Enfermedades de las Cabras/tratamiento farmacológico , Cabras/metabolismo , Inyecciones Intramusculares/veterinaria , Inyecciones Intravenosas/veterinaria , Lactancia/metabolismo , Mastitis/tratamiento farmacológico , Mastitis/veterinaria , Pruebas de Sensibilidad Microbiana , Método de Montecarlo
2.
Encephale ; 42(1): 59-66, 2016 Feb.
Artículo en Francés | MEDLINE | ID: mdl-26350554

RESUMEN

INTRODUCTION: Electroconvulsive therapy (ECT) is most frequently indicated for episodes of melancholic depression, but is also useful in the treatment of maniac syndrome and some schizophrenia subtypes. ECT is part of the treatment of movement disorders, neuroleptic malignant syndrome and even in the treatment of severe conversions. Although the therapeutic results are excellent when used appropriately, the mortality rate is estimated between 2 and 4 for 100,000 shocks. Despite this mortality rate, the benefit-risk ratio remains very positive and serious complications are extremely rare. ECT results in a biphasic cardiological effect: firstly a perstimulus parasympathetic hypertonia contemporary to the seizure's tonic phase, then a phase of contemporary sympathetic hypertonia during the epileptic clonic movement. We will focus on the perstimulus asystole as it is by far the most frequent. Very few cases and even less studies have been referenced in the literature; here, we present a clinical case followed by a discussion. CLINICAL CASE: The patient is in his fifties and has been treated for many years for a unipolar mood disorder with recurrent melancholic depressive episodes. With each new depressive episode, the clinical evolution is rapidly positive after a few sessions of ECT. Maintenance ECT was not retained due to the supra-annual periodicity of the melancholic depressive episodes and rapid recovery after electric treatment. Then, this patient developed another depressive decline in mood comparable to the previous one, despite adapted blood lithium levels associated with a new generation antidepressant treatment. According to his history, a hospitalisation was programmed to carry out a new course of ECT. Considering the short duration of the first seizures, the intensity of the stimulus was progressively increased. At 180 joules, the patient presented an immediate per-stimulus asystole of 20seconds which ceased spontaneously. The specialized cardiologic consultation following the rhythmic episode was reassuring: the patient's cardiac condition remained stable. However, after discussion with the patient and his family, we decided to stop the ECT. Was this a reasonable decision? DISCUSSION: According to the literature, the patient's medical history, sex, psychiatric diagnosis, the shock parameters (level of energy applied, duration of the stimulus, number of shocks) and clinical results, are not predictive factors in the occurrence of an asystole. Concerning the ECT protocol, the vagus nerve seems less stimulated during bifrontal stimulations in opposition to unilateral stimulations. Perasystolic patients are younger and have less prior history of cardiovascular disease or ECG abnormalities. Although the patients receiving ECT are often taking several medications (antipsychotics, benzodiazepines, antidepressants, anticholinergic correctors, calcium channel blockers, loop diuretics, converting enzyme inhibitors), these drugs are not considered as facilitating asystoles. No increase in the frequency of asystole had been observed when taking an average dose psychotropic treatment allowing the continuation of an antidepressant treatment at the recommended dose. Differently, lithium is regularly stopped during the shock phase as it could - even a few days after being stopped - potentiate the effects of succinylcholine and increase the vagal tone. Succinylcholine seems to promote asystole, whilst caffeine, methohexital and trimethaphan do not. The hypersympathetic phase can be controlled by a betablocker (propranolol, esmolol, labetalol) that does not increase the prior risk of asystole. Anticholinergic premedication using atropine does not appear to be systematic and could even potentially induce tachy-dysarrhythmia. However, in the case of perstimulus asystole, most authors recommend continuing the shocks with doses of atropine around 0.4 to 1mg. PHYSIOPATHOLOGY: Vagal stimulation is preferentially central and directly linked to the electric excitation of the lateral dorsal motor nucleus of the vagus nerve. Younger patients with no cardiac history are more at risk. This could be explained by the fact that juvenile tissue conducts electricity more rapidly than senescent (the difference being probably due to the fibrosis and adipose tissue which reduce its conductive capacity). Finally, it is appropriate to question the direct therapeutic aspect of vagal stimulation which constitutes an experimental treatment of resistant depression. CONCLUSIONS: The occurrence of perstimulus asystole is not considered as a serious complication of ECT and therefore as a contra-indication to any future sessions. On the contrary, most authors are campaigning for the continuation of shocks with the possibility of adding prophylactic intravenous atropine. Cardiac arrest reminds us that ECT requires a special attention to its cardiovascular effect, which emphasizes the role of interdisciplinarity between anaesthesiologists and psychiatrists.


Asunto(s)
Trastorno Depresivo Mayor/complicaciones , Trastorno Depresivo Mayor/terapia , Terapia Electroconvulsiva/efectos adversos , Paro Cardíaco/etiología , Envejecimiento , Anestesia , Antiarrítmicos/uso terapéutico , Atropina/uso terapéutico , Contraindicaciones , Conductividad Eléctrica , Paro Cardíaco/prevención & control , Humanos , Masculino , Persona de Mediana Edad , Factores de Riesgo , Estimulación del Nervio Vago
3.
Br Poult Sci ; 54(3): 391-7, 2013 Jun.
Artículo en Inglés | MEDLINE | ID: mdl-23796120

RESUMEN

1. The objective of the study was to evaluate the comparative pharmacokinetic behaviour of enrofloxacin in adult ostriches after single and multiple intramuscular (IM) and subcutaneous (SC) administrations. In addition, tissue tolerance was evaluated. 2. Enrofloxacin was well absorbed, but showed a short permanence after both administration routes. After multiple dose administrations the maximum and minimum peak plasma concentrations were very similar for both routes, obtaining a steady state phase from the second dose that extended until the last evaluated administration. 3. There was no significant accumulation after multiple IM or SC doses; however, there were differences in a fluctuation index after multiple intramuscular administrations that could be related to muscle damage. 4. The different microbiological efficacy indicators (PK/PD indices) obtained, the pharmacokinetic behaviour and CK serum concentrations suggest that subcutaneous enrofloxacin administration of 15 mg/kg every 12 h produce and maintain an efficient concentration of antibiotic that is a safer and more effective therapeutic option than intramuscular administration.


Asunto(s)
Antibacterianos/administración & dosificación , Antibacterianos/farmacocinética , Fluoroquinolonas/administración & dosificación , Fluoroquinolonas/farmacocinética , Struthioniformes/metabolismo , Animales , Antibacterianos/sangre , Ciprofloxacina/administración & dosificación , Ciprofloxacina/sangre , Estudios Cruzados , Enrofloxacina , Femenino , Fluoroquinolonas/sangre , Inyecciones Intramusculares , Inyecciones Subcutáneas , Masculino
4.
Neurologia ; 28(9): 529-34, 2013.
Artículo en Inglés, Español | MEDLINE | ID: mdl-23751554

RESUMEN

INTRODUCTION: Cardiac myxoma is an important but uncommon cause of stroke in younger patients. Few published case series analyse the frequency and clinical presentation of neurological complications in patients with myxoma. OBJECTIVE: To list all neurological complications from cardiac myxoma recorded in our hospital in the past 28 years. PATIENTS AND METHODS: We retrospectively reviewed the neurological manifestations of cardiac myxoma in patients treated in our hospital between December 1983 and March 2012. RESULTS: Of the 36 patients with cardiac myxoma, 8 (22%) presented neurological manifestations. Half were women and mean age of patients was 52.4 ± 11.6 years. Sudden-onset hemiparesis was the most frequent neurological symptom (63%). Established ischaemic stroke was the most common clinical manifestation (75%), followed by transient ischemic attack. The most commonly affected territory corresponded to the middle cerebral artery. Myxoma was diagnosed by echocardiography in all cases. Mean myxoma size was 4.1cm and most of the tumours (63%) had a polypoid surface. All tumours were successfully removed by surgery. There were no in-hospital deaths. CONCLUSIONS: Cardiac myxomas frequently present with neurological symptoms, especially ischaemic events (established stroke or transient ischaemic attack), in younger patients with no cardiovascular risk factors. The anterior circulation is more frequently affected, especially the middle cerebral artery. Echocardiography can facilitate prompt diagnosis and early treatment of the lesion.


Asunto(s)
Neoplasias Cardíacas/complicaciones , Mixoma/complicaciones , Enfermedades del Sistema Nervioso/etiología , Adulto , Isquemia Encefálica/etiología , Electrocardiografía , Femenino , Estudios de Seguimiento , Neoplasias Cardíacas/patología , Humanos , Infarto de la Arteria Cerebral Media/etiología , Masculino , Persona de Mediana Edad , Mixoma/patología , Enfermedades del Sistema Nervioso/patología , Neuroimagen , Paresia/etiología , Estudios Retrospectivos , Accidente Cerebrovascular/etiología , Resultado del Tratamiento
5.
Rehabilitacion (Madr) ; 56(3): 226-236, 2022.
Artículo en Español | MEDLINE | ID: mdl-35523619

RESUMEN

The main objective of the study is to analyse the scientific evolution of the research field of fibromyalgia and biomechanics. A search was carried out in Web of Science, from 1985 to 2021. With those results, a bibliometric map of keywords was created with VOSviewer. On top of that, scientific mapping and performance analysis were also conducted using SciMAT. A total of 233 articles from around the world were analysed, highlighting the production of the USA and Spain. The results show great diversity in topics with 54 different topics and 33 keywords. Although most of the topics found are not widely developed except the topics of physical activity and symptomatology. In conclusion, the study of fibromyalgia and biomechanics has generally grown over time.


Asunto(s)
Fibromialgia , Bibliometría , Fenómenos Biomecánicos , Humanos , España
6.
Ann Hum Biol ; 37(6): 801-19, 2010 Nov.
Artículo en Inglés | MEDLINE | ID: mdl-20515366

RESUMEN

BACKGROUND: CODIS-STRs in Native Mexican groups have rarely been analysed for human identification and anthropological purposes. AIM: To analyse the genetic relationships and population structure among three Native Mexican groups from Mesoamerica. SUBJECTS AND METHODS: 531 unrelated Native individuals from Mexico were PCR-typed for 15 and 9 autosomal STRs (Identifiler™ and Profiler™ kits, respectively), including five population samples: Purépechas (Mountain, Valley and Lake), Triquis and Yucatec Mayas. Previously published STR data were included in the analyses. RESULTS: Allele frequencies and statistical parameters of forensic importance were estimated by population. The majority of Native groups were not differentiated pairwise, excepting Triquis and Purépechas, which was attributable to their relative geographic and cultural isolation. Although Mayas, Triquis and Purépechas-Mountain presented the highest number of private alleles, suggesting recurrent gene flow, the elevated differentiation of Triquis indicates a different origin of this gene flow. Interestingly, Huastecos and Mayas were not differentiated, which is in agreement with the archaeological hypothesis that Huastecos represent an ancestral Maya group. Interpopulation variability was greater in Natives than in Mestizos, both significant. CONCLUSION: Although results suggest that European admixture has increased the similarity between Native Mexican groups, the differentiation and inconsistent clustering by language or geography stresses the importance of serial founder effect and/or genetic drift in showing their present genetic relationships.


Asunto(s)
Etnicidad/genética , Indígenas Norteamericanos/genética , Repeticiones de Microsatélite , Demografía , Genética Forense , Amplificación de Genes , Flujo Génico , Frecuencia de los Genes , Flujo Genético , Marcadores Genéticos , Variación Genética , Genotipo , Geografía , Haplotipos , Humanos , México , Técnicas de Diagnóstico Molecular , Reacción en Cadena de la Polimerasa , Población Blanca/genética
7.
J Cell Biol ; 88(2): 373-9, 1981 Feb.
Artículo en Inglés | MEDLINE | ID: mdl-7204499

RESUMEN

A dramatic difference is observed in the intracellular distribution of the high mobility group (HMG) proteins when chicken embryo fibroblasts are fractionated into nucleus and cytoplasm by either mass enucleation of cytochalasin-B-treated cells or by differential centrifugation of mechanically disrupted cells. Nuclei (karyoplasts) obtained by cytochalasin B treatment of cells contain more than 90 percent of the HMG 1, while enucleated cytoplasts contain the remainder. A similar distribution between karyoplasts and cytoplasts is observed for the H1 histones and the nucleosomal core histones as anticipated. The presence of these proteins, in low amounts, in the cytoplast preparation can be accounted for by the small percentage of unenucleated cells present. In contrast, the nuclei isolated from mechanically disrupted cells contain only 30-40 percent of the total HMGs 1 and 2, the remainder being recovered in the cytosol fraction. No histone is observed in the cytosol fraction. Unike the higher molecular weight HMGs, most of the HMGs 14 and 17 sediment with the nuclei after cell lysis by mechanical disruption. The distribution of HMGs is unaffected by incubating cells with cytochalasin B and mechanically fractionating rather than enucleating them. Therefore, the dramatic difference in HMG 1 distribution observed using the two fractionation techniques cannot be explained by a cytochalasin-B-induced redistribution. On reextraction and sedimentation of isolated nuclei obtained by mechanical cell disruption, only 8 percent of the HMG 1 is released to the supernate. Thus, the majority of the HMG 1 originally isolated with these nuclei, representing 35 percent of the total HMG 1, is stably bound, as is all the HMGs 14 and 17. The remaining 65 percent of the HMGs 1 and 2 is unstably bound and leaks to the cytosol fraction under the conditions of mechanical disruption. It is suggested that the unstably bound HMGs form a protein pool capable of equilibrating between cytoplasm and stably bound HMGs.


Asunto(s)
Núcleo Celular/metabolismo , Proteínas Cromosómicas no Histona/metabolismo , Animales , Fraccionamiento Celular , Embrión de Pollo , Citocalasina B/farmacología , Citoplasma/metabolismo , Histonas/metabolismo , Músculos
8.
J Cell Biol ; 96(6): 1815-9, 1983 Jun.
Artículo en Inglés | MEDLINE | ID: mdl-6189844

RESUMEN

When fused with mouse L-cell cytoplasts, chick erythrocyte nuclei enlarge, take up proteins from the host cytoplasm, and recommence RNA synthesis. We found that during this transition the erythrocyte nuclei gain an internal nuclear matrix, thus providing a novel approach to questions concerning the nature of the salt-resistant intranuclear skeleton. A new method for preparation and examination of the nuclear matrix in situ is also described.


Asunto(s)
Núcleo Celular/metabolismo , Eritrocitos/ultraestructura , Animales , Fusión Celular , Embrión de Pollo , Cromatina/metabolismo , Replicación del ADN , Ratones , ARN/biosíntesis , Factores de Tiempo
9.
Eur J Neurol ; 16(3): 297-309, 2009 Mar.
Artículo en Inglés | MEDLINE | ID: mdl-19364361

RESUMEN

Tauopathies with parkinsonism represent a spectrum of disease entities unified by the pathologic accumulation of hyperphosphorylated tau protein fragments within the central nervous system. These pathologic characteristics suggest shared pathogenetic pathways and possible molecular targets for disease-modifying therapeutic interventions. Natural history studies, for instance, in progressive supranuclear palsy, frontotemporal dementia with parkinsonism linked to chromosome 17, corticobasal degeneration, and Niemann-Pick disease type C as well as in amyotrophic lateral sclerosis/Parkinson-dementia complex permit clinical characterization of the disease phenotypes and are crucial to the development and validation of biological markers for differential diagnostics and disease monitoring, for example, by use of neuroimaging or proteomic approaches. The wide pathologic and clinical spectrum of the tauopathies with parkinsonism is reviewed in this article, and perspectives on future advances in the understanding of the pathogenesis are given, together with potential therapeutic strategies.


Asunto(s)
Trastornos Parkinsonianos/complicaciones , Tauopatías/complicaciones , Animales , Biomarcadores , Demencia/complicaciones , Demencia/genética , Demencia/fisiopatología , Diseño de Fármacos , Geografía , Humanos , Proteína 2 Quinasa Serina-Treonina Rica en Repeticiones de Leucina , Modelos Biológicos , Mutación , Enfermedad de Niemann-Pick Tipo C/complicaciones , Enfermedad de Niemann-Pick Tipo C/diagnóstico , Enfermedad de Niemann-Pick Tipo C/fisiopatología , Enfermedad de Parkinson Posencefalítica/complicaciones , Enfermedad de Parkinson Posencefalítica/fisiopatología , Trastornos Parkinsonianos/patología , Trastornos Parkinsonianos/fisiopatología , Trastornos Parkinsonianos/terapia , Enfermedad de Pick/complicaciones , Enfermedad de Pick/patología , Proteínas Serina-Treonina Quinasas/genética , Parálisis Supranuclear Progresiva/complicaciones , Parálisis Supranuclear Progresiva/diagnóstico , Parálisis Supranuclear Progresiva/fisiopatología , Tauopatías/patología , Tauopatías/fisiopatología , Tauopatías/terapia , Proteínas tau/genética
10.
Neuron ; 10(4): 599-611, 1993 Apr.
Artículo en Inglés | MEDLINE | ID: mdl-8476611

RESUMEN

By using spinal cord neurons cultured in chemically defined medium, a double labeling procedure, and blockage with antisense oligonucleotides, we show that induction of c-fos and the subsequent transactivation of the prodynorphin gene are coupled events, triggered by serotonin1A receptor agonists. Addition of the specific 1A agonist 8-hydroxy-2-(di-n-propylamino)-tetralin (8-OH-DPAT) to the culture, at concentrations similar to that needed for transactivation of the prodynorphin gene, also significantly increases cAMP levels. Furthermore, in rats depleted of serotonin by intrathecal administration of 5,7-dihydroxytryptamine, the induction of prodynorphin after noxious stimulation is dramatically decreased compared with the induction in sham-operated rats. These results suggest that the expression of the prodynorphin gene in spinal cord is under the control of the raphe-spinal efferents containing serotonin.


Asunto(s)
Encefalinas/genética , Dolor/fisiopatología , Precursores de Proteínas/genética , Proteínas Proto-Oncogénicas c-fos/fisiología , Receptores de Serotonina/fisiología , Médula Espinal/fisiología , Activación Transcripcional , 8-Hidroxi-2-(di-n-propilamino)tetralin/farmacología , Vías Aferentes/fisiología , Animales , Secuencia de Bases , Células Cultivadas , Desnervación , Regulación de la Expresión Génica , Genes , Datos de Secuencia Molecular , Neuronas/fisiología , Sondas de Oligonucleótidos/genética , Médula Espinal/citología
11.
Neuroscience ; 157(4): 772-80, 2008 Dec 10.
Artículo en Inglés | MEDLINE | ID: mdl-18951953

RESUMEN

Glycogen synthase kinase-3beta (GSK-3beta) has been proposed as the main kinase able to phosphorylate tau aberrantly in Alzheimer's disease and in related tauopathies. We have previously generated a double transgenic mouse line overexpressing the enzyme GSK-3beta and tau protein carrying a triple frontotemporal dementia and parkinsonism linked to chromosome 17 mutation whose expression patterns overlap in CA1 (pyramidal neurons) and dentate gyrus (granular neurons). Here, we have used this transgenic model to analyze how axonal and somatodendritic neuronal compartments are affected in the hippocampus. Our data demonstrate that neuronal subpopulations respond differentially to increased GSK-3 activity. Thus, dentate gyrus granular neurons undergo apoptotic death with subsequent degeneration of the mossy fibers, while CA1 pyramidal neurons accumulate hyperphosphorylated tau both in the axonal and in the somatodendritic compartments. These studies also allow us to propose a model of spreading of pathology through the hippocampus as a consequence of GSK-3 and tau dysregulation.


Asunto(s)
Diferenciación Celular/genética , Glucógeno Sintasa Quinasa 3/genética , Hipocampo/citología , Neuronas/clasificación , Neuronas/fisiología , Proteínas tau/genética , Factores de Edad , Animales , Anticuerpos Monoclonales/metabolismo , Quinasa de la Proteína Quinasa Dependiente de Calcio-Calmodulina/genética , Caspasa 3/metabolismo , Cromosomas Humanos Par 17/genética , Modelos Animales de Enfermedad , Proteína Ácida Fibrilar de la Glía/metabolismo , Glucógeno Sintasa Quinasa 3/metabolismo , Glucógeno Sintasa Quinasa 3 beta , Humanos , Indoles , Ratones , Ratones Endogámicos C57BL , Ratones Transgénicos , Microscopía Electrónica de Transmisión , Mutación/genética , Enfermedades Neurodegenerativas/genética , Enfermedades Neurodegenerativas/patología , Neuronas/ultraestructura , Proteínas tau/metabolismo
12.
Neurodegener Dis ; 5(3-4): 247-9, 2008.
Artículo en Inglés | MEDLINE | ID: mdl-18322403

RESUMEN

Alzheimer's disease is characterized by the presence of two histopathological aberrant structures, the senile plaques and the neurofibrillary tangles. The main component of these tangles is the cytoskeletal protein tau in hyperphosphorylated form. Since a main tau kinase is glycogen synthase kinase 3 (GSK-3), the use of specific GSK-3 inhibitors, like lithium, could be a potential therapy in Alzheimer's disease. In this short article, we have done a review on tau phosphorylation in Alzheimer's disease and other tauopathies, and on the inhibition of kinases like GSK-3, involved in tau modification.


Asunto(s)
Enfermedad de Alzheimer/tratamiento farmacológico , Compuestos de Litio/uso terapéutico , Fármacos Neuroprotectores/uso terapéutico , Enfermedad de Alzheimer/enzimología , Enfermedad de Alzheimer/patología , Animales , Glucógeno Sintasa Quinasa 3/antagonistas & inhibidores , Glucógeno Sintasa Quinasa 3/metabolismo , Glucógeno Sintasa Quinasa 3 beta , Humanos , Compuestos de Litio/farmacología , Fármacos Neuroprotectores/farmacología
13.
Vet Res Commun ; 32(4): 275-9, 2008 Apr.
Artículo en Inglés | MEDLINE | ID: mdl-18247149

RESUMEN

This study compared pharmacokinetic profiles in cattle dosed subcutaneously with two different formulations of enrofloxacin (5% and 10%) at a dose of 5 mg/kg. Plasma concentrations of enrofloxacin and its active metabolite, ciprofloxacin, were determined by a HPLC/u.v. method. The pharmacokinetic parameters of enrofloxacin and its metabolite were similar in both injectable formulations. Enrofloxacin peak plasma concentration (5%: 0.73 +/- 0.32; 10%: 0.60 +/- 0.14 microg/mL) was reached at 1.21 +/- 0.52 and 1.38 +/- 0.52 h to 5 and 10%, respectively. The terminal half-live and area under curve were 2.34 +/- 0.46 and 2.59 +/- 0.46 h, and 3.09 +/- 0.81 and 2.93 +/- 0.58 microg x h/mL, to 5 and 10%, respectively. The AUC/MIC(90) and Cmax/MIC(90) ratios for both formulations exceed the proposed threshold values for optimized efficacy and minimized resistance development whilst treating infections or septicaemia caused by P. multocida and E. coli.


Asunto(s)
Antibacterianos/farmacocinética , Bovinos/metabolismo , Ciprofloxacina/farmacocinética , Fluoroquinolonas/farmacocinética , Animales , Antibacterianos/sangre , Antibacterianos/toxicidad , Bovinos/sangre , Ciprofloxacina/sangre , Enrofloxacina , Fluoroquinolonas/sangre , Fluoroquinolonas/uso terapéutico , Masculino
14.
Mol Cell Biol ; 1(12): 1163-76, 1981 Dec.
Artículo en Inglés | MEDLINE | ID: mdl-7346715

RESUMEN

The polypeptides synthesized by mature embryonic erythrocytes prepared from the peripheral blood of 14- to 15-day-old chicken embryos were analyzed by two-dimensional gel electrophoresis. Fewer than 200 species of polypeptides were detected; the major polypeptides made at this time were identified as the alpha A-, alpha D-, and beta-globin chains. The dormant erythrocyte nuclei were next reactivated to transcriptional competence by transplantation into enucleated mouse or chicken embryo fibroblasts, with frequencies of cytoplast renucleation of about 50 and 90%, respectively. Since large numbers of hybrid cells could be constructed, a biochemical analysis was possible. Electrophoretic analysis of the [35S]methionine-labeled polypeptides made in the hybrid cell types showed that polypeptides having the mobilities of only two (alpha A and alpha D) of the three major adult globin chains were made as major constituents of the hybrid cells. However, analysis of 14C-amino acid-labeled polypeptides revealed that a beta-like polypeptide that lacked methionine was also synthesized in large amounts. This polypeptide was tentatively identified as the early embryonic globin species rho. Globin synthesis was detected as early as 3 h after nuclear transplantation and as late as 18 h, the last time measured in these experiments. It appeared that globin polypeptides made at very early times were translated at least partially from chicken messenger ribonucleic acid introduced into the hybrid cells during fusion, whereas those made at later times were translated primarily from newly synthesized globin messenger ribonucleic acid. The potential usefulness of this hybrid cell system in analyzing mechanisms regulating globin gene expression is discussed.


Asunto(s)
Regulación de la Expresión Génica , Globinas/biosíntesis , Animales , Núcleo Celular/fisiología , Embrión de Pollo , Células Clonales , Citoplasma/fisiología , Eritrocitos/fisiología , Fibroblastos , Células Híbridas , Células L , Ratones , Biosíntesis de Proteínas
15.
Mol Cell Biol ; 7(8): 3012-7, 1987 Aug.
Artículo en Inglés | MEDLINE | ID: mdl-3670304

RESUMEN

Material was introduced into cultures of cells by using the method of scrape loading, in which cells are simply rubbed from the surface of a plastic tissue culture dish by a rubber-tipped rod in the presence of a macromolecule of interest. The volume of solution introduced into cells was comparable to that generally injected in the direct microinjection method with glass capillaries, that is, about 50 to 100 fl per cell. Genetic defects (lack of hypoxanthine-guanine phosphoribosyltransferase and thymidine kinase) in several cell lines were transiently corrected by scraping the cells in the presence of crude cell extracts prepared from wild-type cells.


Asunto(s)
Técnicas de Cultivo/métodos , Proteínas/genética , Animales , Línea Celular , Células Cultivadas , Humanos , Hipoxantina Fosforribosiltransferasa/genética , Hipoxantina Fosforribosiltransferasa/metabolismo , Proteínas/metabolismo
16.
Mol Cell Biol ; 3(10): 1866-81, 1983 Oct.
Artículo en Inglés | MEDLINE | ID: mdl-6646128

RESUMEN

Conditions for the preparation, purification, and maintenance of karyoplasts which could regenerate to reform whole viable cells were defined. Results of biochemical analyses of such karyoplasts at various times during regeneration indicated that a reproducible biosynthetic program was followed. Thus, an examination of the polypeptides made during regeneration by two-dimensional gel electrophoresis showed that the pattern of radiolabeled polypeptides synthesized at each time studied was specific and was significantly different from that observed at other times during regeneration. Polypeptides associated with three major cellular fractions--nuclear, cytoskeletal-microtrabecular, and soluble--were among the most dramatically regulated molecules. Other polypeptides, such as the major components of microfilaments and intermediate filaments, were synthesized at relatively constant rates and were assembled into structures throughout regeneration. Likewise, microtubules appeared to be reformed throughout regeneration, even in the absence of identifiable centriole-associated organizing centers. Finally, analysis of DNA synthesis by autoradiography showed that, even when prepared from whole cells synchronized at the G1/S interface, karyoplasts could not begin making DNA until they had regenerated an almost complete complement of cytoplasm.


Asunto(s)
Núcleo Celular/metabolismo , Citoplasma/metabolismo , Organoides/metabolismo , Animales , Células Cultivadas , Chlorocebus aethiops , Replicación del ADN , Fibroblastos/ultraestructura , Células HeLa/ultraestructura , Humanos , Riñón , Macropodidae , Biosíntesis de Péptidos
17.
Vet Rec ; 161(4): 133-6, 2007 Jul 28.
Artículo en Inglés | MEDLINE | ID: mdl-17660467

RESUMEN

Six donkeys each received 2 mg/kg marbofloxacin as a 10 per cent aqueous solution administered intravenously. Principal pharmacokinetic parameters were determined and two efficacy indices were computed by using pharmacokinetic parameters and selected mic90 values of marbofloxacin against pathogenic equine strains to predict the efficacy of the drug at this dose. The pharmacokinetics of marbofloxacin in donkeys was characterised by a large mean volume of distribution at a steady state (1.15 [0.09] l/kg) and a long mean (sd) elimination half-life of 9.24 (1.96) hours. It was also characterised by a relatively slow total body clearance of 0.10 (0.02) l/kg/hour, slower than in horses. Using mic90 values of marbofloxacin against pathogenic equine strains with a daily dose of 2 mg/kg, appropriate values of efficacy indicators were obtained only for Enterobacteriaceae. Daily intravenous doses of 0.33, 2.62 and 20 mg/kg were calculated for evaluation in clinical trials of infections due to Enterobacteriaceae, Staphylococcus aureus and Streptococci, respectively.


Asunto(s)
Antibacterianos/farmacocinética , Infecciones Bacterianas/veterinaria , Equidae/metabolismo , Fluoroquinolonas/farmacocinética , Caballos/metabolismo , Quinolonas/farmacocinética , Animales , Área Bajo la Curva , Infecciones Bacterianas/tratamiento farmacológico , Infecciones Bacterianas/metabolismo , Equidae/sangre , Femenino , Semivida , Enfermedades de los Caballos/tratamiento farmacológico , Enfermedades de los Caballos/metabolismo , Caballos/sangre , Inyecciones Intravenosas/veterinaria , Masculino , Tasa de Depuración Metabólica , Especificidad de la Especie , Resultado del Tratamiento
18.
Rehabilitación (Madr., Ed. impr.) ; 56(3): 226-236, Jul - Sep 2022. graf
Artículo en Español | IBECS (España) | ID: ibc-204913

RESUMEN

El objetivo principal del estudio es analizar la evolución científica del campo de investigación de la fibromialgia y la biomecánica. Para ello, se llevó a cabo una búsqueda en Web of Science, desde 1985 hasta 2021, con cuyos resultados se creó un mapa bibliométrico de palabras clave con VOSviewer. También se realizó un de mapeo científico y análisis del rendimiento mediante SciMAT. Se analizaron 233 artículos de todo el mundo, destacando la producción de EE. UU. y España. Los resultados muestran una gran diversidad temática con 54 temáticas diferentes y 33 palabras clave. Si bien la mayoría de temas no están muy desarrollados salvo la actividad física y la sintomatología. En conclusión, el estudio de la fibromialgia y la biomecánica ha crecido de forma general a lo largo del tiempo.(AU)


The main objective of the study is to analyse the scientific evolution of the research field of fibromyalgia and biomechanics. A search was carried out in Web of Science, from 1985 to 2021. With those results, a bibliometric map of keywords was created with VOSviewer. On top of that, scientific mapping and performance analysis were also conducted using SciMAT. A total of 233 articles from around the world were analysed, highlighting the production of the USA and Spain. The results show great diversity in topics with 54 different topics and 33 keywords. Although most of the topics found are not widely developed except the topics of physical activity and symptomatology. In conclusion, the study of fibromyalgia and biomechanics has generally grown over time.(AU)


Asunto(s)
Humanos , Masculino , Femenino , 50088 , Bibliometría , Fibromialgia , Biología de Sistemas , Dolor Crónico , Dolor Musculoesquelético , Manejo del Dolor , Medicina Física y Rehabilitación
19.
Oncogene ; 20(23): 2889-99, 2001 May 24.
Artículo en Inglés | MEDLINE | ID: mdl-11420701

RESUMEN

Cyclin-dependent kinase 6(cdk6) is present in randomly proliferating cultures of 3T3 cells but has little detectable enzymatic activity. Significant activity is detected only during a short period in early G1 phase. To examine the possible functions of cdk6 in 3T3 cells, lines stably over-expressing cdk6 were constructed and compared to normal 3T3 cells or cell lines with reduced cdk6 levels due to expression of a dominant-negative form of the protein. Over-expression of cdk6 in cells, which led to high levels of activity even in proliferating cultures, had dramatic effects. Cell lines stably over-expressing wild-type cdk6 had a markedly reduced growth rate compared to parental 3T3 cells or lines expressing a dominant-negative form of cdk6. They also over-produced the p53 and p130 proteins and had increased sensitivity to UV-irradiation. Irradiation resulted in accumulation of the Bax protein and rapid cell death. Levels of p53 and p130 proteins were down-regulated and the growth rate of the cells was increased by introduction of the dominant-negative form of cdk6 into cells over-expressing cdk6, indicating that cdk6 is involved in the overproduction of p53 and p130. The results suggest that cdk6, through regulation of growth-suppressing molecules, may play a role in halting cellular growth when proliferation is inappropriate.


Asunto(s)
Quinasas Ciclina-Dependientes , Proteínas Serina-Treonina Quinasas/metabolismo , Proteínas Proto-Oncogénicas c-bcl-2 , Proteína p53 Supresora de Tumor/metabolismo , Células 3T3/efectos de la radiación , Animales , División Celular/genética , Línea Celular/efectos de la radiación , Medio de Cultivo Libre de Suero , Quinasa 6 Dependiente de la Ciclina , Ratones , Proteínas Serina-Treonina Quinasas/genética , Proteínas Proto-Oncogénicas/genética , Proteínas Proto-Oncogénicas/metabolismo , Proteínas Proto-Oncogénicas/efectos de la radiación , Transfección , Proteína p53 Supresora de Tumor/genética , Proteína X Asociada a bcl-2
20.
Oncogene ; 6(2): 223-7, 1991 Feb.
Artículo en Inglés | MEDLINE | ID: mdl-1900356

RESUMEN

Noxious stimulation in vivo provokes the transcriptional activation of several genes which are thought to play an important role in the phenomena of stress and pain. In the rat, the expression of the c-fos proto-oncogene is rapidly induced upon noxious stimulation in defined neurons in the dorsal horn of the spinal cord. Interestingly, expression of the prodynorphin gene, which is thought to be involved in the endogenous mechanisms for pain/stress control, also localizes in the same anatomical area. Fos proteins are known to associate in transcriptional complexes with the products of the jun family constituting nuclear factor AP-1. These considerations prompted us to analyse the expression of the jun gene family members c-jun, jun B and jun D in rats subjected to noxious stimulation. We present data indicating that in unstimulated animals the transcripts of the three genes are differentially expressed and abundant within the various laminas of the lumbar spinal cord. Surprisingly, upon stimulation only the jun B transcript is augmented, being co-localized with Fos in a subset of neurons of the medial dorsal horn.


Asunto(s)
Proteínas de Unión al ADN/genética , Expresión Génica , Neuronas/metabolismo , Proteínas Proto-Oncogénicas/genética , Proto-Oncogenes , Médula Espinal/metabolismo , Factores de Transcripción/genética , Animales , Masculino , Dolor/fisiopatología , Proteínas Proto-Oncogénicas c-fos , Proteínas Proto-Oncogénicas c-jun , ARN Mensajero/análisis , Ratas , Ratas Endogámicas , Transcripción Genética
SELECCIÓN DE REFERENCIAS
Detalles de la búsqueda